alanylglutamine has been researched along with Cholera Infantum in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Debauche, C; Schaible, T; Struijs, MC; te Beest, H; Tibboel, D; van Elburg, RM | 1 |
Izotova, OG; Kalinin, EIu; Karimov, SKh; Katsadze, MA; Miroshnichenko, AG; Rakhmonov, DA | 1 |
Boelens, PG; De Bandt, JP; Dejong, CH; Deutz, NE; Ligthart-Melis, GC; van de Poll, MC; van den Tol, MP; van Leeuwen, PA; van Schaik, C; Vermeulen, MA | 1 |
1 trial(s) available for alanylglutamine and Cholera Infantum
Article | Year |
---|---|
Efficacy and safety of a parenteral amino acid solution containing alanyl-glutamine versus standard solution in infants: a first-in-man randomized double-blind trial.
Topics: Amino Acids; Birth Weight; Dipeptides; Double-Blind Method; Endpoint Determination; Female; Gastrointestinal Diseases; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Parenteral Nutrition Solutions; Pilot Projects | 2013 |
2 other study(ies) available for alanylglutamine and Cholera Infantum
Article | Year |
---|---|
[Objectivization of the diagnostics and control of treatment of paresis of the gastrointestinal tract in diffuse peritonitis].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dipeptides; Electric Stimulation Therapy; Follow-Up Studies; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Laparoscopy; Middle Aged; Parenteral Nutrition; Peritonitis; Severity of Illness Index; Sorption Detoxification; Treatment Outcome | 2008 |
Enteral administration of alanyl-[2-(15)N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans.
Topics: Arginine; Body Mass Index; Citrulline; Dipeptides; Enteral Nutrition; Female; Gastrointestinal Diseases; Glutamine; Humans; Infusions, Intravenous; Isotope Labeling; Male; Middle Aged; Neoplasms; Nitrogen Isotopes | 2009 |